126098001: Conjugated estrogen (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Sex hormone (substance)\Substance with estrogen receptor agonist mechanism of action (substance)\Conjugated estrogen
\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Steroid hormone\Conjugated estrogen
\Substance categorized by disposition\Receptor agonist\Substance with estrogen receptor agonist mechanism of action (substance)\Conjugated estrogen

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\...

\Sex hormone (substance)\Substance with estrogen receptor agonist mechanism of action (substance)\Conjugated estrogen

\Steroid hormone\Conjugated estrogen

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid\Steroid hormone\Conjugated estrogen

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

9262019 Conjugated estrogen en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

730016013 Conjugated estrogen (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

30121000188111 estrogènes conjuguès fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Conjugated estrogen	Is a	estrogeno	false	Inferred relationship	Some
Conjugated estrogen	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Estrogen	false	Inferred relationship	Some
Conjugated estrogen	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Gonadal hormone	false	Inferred relationship	Some
Conjugated estrogen	Is a	Steroid hormone	true	Inferred relationship	Some
Conjugated estrogen	Is a	Substance with estrogen receptor agonist mechanism of action (substance)	true	Inferred relationship	Some
Conjugated estrogen	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Estrogen receptor agonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing conjugated estrogen (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogens adverse reaction	Causative agent (attribute)	True	Conjugated estrogen	Inferred relationship	Some	1
Allergy to conjugated estrogen (finding)	Causative agent (attribute)	False	Conjugated estrogen	Inferred relationship	Some
Conjugated estrogens [endocrine use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Conjugated estrogen 625 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Conjugated estrogen 1.25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Conjug estrogen [topical vaginal use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Conjugated estrogen 625 microgram/g vaginal cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Medroxyprogesterone 5mg / Conjugated Estrogens 625microgram tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Conjugated estrogen 900 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Conjugated estrogen 450 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Conjugated estrogen 300 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Product containing conjugated estrogen and medroxyprogesterone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Product containing conjugated estrogen and norgestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogens synthetic A	Is a	False	Conjugated estrogen	Inferred relationship	Some
Conjugated estrogens synthetic B	Is a	False	Conjugated estrogen	Inferred relationship	Some
Product containing precisely conjugated estrogen 2.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some
Allergy to conjugated estrogen (finding)	Causative agent (attribute)	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen-containing product in vaginal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing bazedoxifene and conjugated estrogen (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing bazedoxifene and conjugated estrogen in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 1.25 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 1.25 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	2
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Conjugated estrogen	Inferred relationship	Some	2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Conjugated estrogen	Inferred relationship	Some	2
Conjugated estrogen 900 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 900 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 450 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 450 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 300 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 300 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 2.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 2.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Conjugated estrogen	Inferred relationship	Some	2
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	2
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Conjugated estrogen	Inferred relationship	Some	2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Conjugated estrogen	Inferred relationship	Some	2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Conjugated estrogen	Inferred relationship	Some	2
Conjugated estrogen 900 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 450 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 300 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Conjugated estrogen	Inferred relationship	Some	2
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Conjugated estrogen	Inferred relationship	Some	2
Product containing precisely conjugated estrogen 2.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 1.25 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Conjugated estrogen	Inferred relationship	Some	2
Conjugated estrogen-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing conjugated estrogen and medroxyprogesterone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen- and norgestrel-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing conjugated estrogen in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram/g vaginal cream	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram/g vaginal cream	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing only bazedoxifene and conjugated estrogen (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing only conjugated estrogen and medroxyprogesterone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing only conjugated estrogen and norgestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen and medroxyprogesterone only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen and norgestrel only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing only conjugated estrogen in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing only conjugated estrogen in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing only conjugated estrogen in vaginal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Bazedoxifene and conjugated estrogen only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing conjugated estrogen and esterified estrogen and medroxyprogesterone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing only conjugated estrogen and esterified estrogen and medroxyprogesterone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen- and esterified estrogen- and medroxyprogesterone-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen and esterified estrogen and medroxyprogesterone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Product containing precisely conjugated estrogen 450 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 2.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 2.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Conjugated estrogen	Inferred relationship	Some	1
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Conjugated estrogen	Inferred relationship	Some	1

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
9262019	Conjugated estrogen	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
730016013	Conjugated estrogen (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
30121000188111	estrogènes conjuguès	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module